MIBiG 2.0: a repository for biosynthetic gene clusters of known function.
Kautsar SA, Blin K, Shaw S, Navarro-Muñoz JC, Terlouw BR, van der Hooft JJJ, van Santen JA, Tracanna V, Suarez Duran HG, Pascal Andreu V, Selem-Mojica N, Alanjary M, Robinson SL, Lund G, Epstein SC, Sisto AC, Charkoudian LK, Collemare J, Linington RG, Weber T, Medema MH. · 2020
Read MIBiG 2.0: a repository for biosynthetic gene clusters of known function. by Kautsar SA, Blin K, Shaw S, Navarro-Muñoz JC, Terlouw BR, van der Hooft JJJ, van Santen JA, Tracanna V, Suarez Duran HG, Pascal Andreu V, Selem-Mojica N, Alanjary M, Robinson SL, Lund G, Epstein SC, Sisto AC, Charkoudian LK, Collemare J, Linington RG, Weber T, Medema MH. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7145714.txt.
Introduction
Kautsar and co-authors present MIBiG 2.0, the repository for gene clusters that build specialised natural compounds, in Nucleic Acids Research. Microbes and fungi make many valuable chemicals, from antibiotics to pigments, using clusters of cooperating genes. Genome mining software predicts thousands of candidate clusters, but judging them requires a reference set of proven ones.
Since the standard launched in 2015, 851 new clusters have been added, and every entry was hand-checked again for annotation quality. The data schema was redesigned so future entries stay compliant. New search tools, a statistics page, and links out to chemical structure databases improve use. The repository underpins drug discovery from microbial genomes.
Catalog record
| CREATOR | Kautsar SA, Blin K, Shaw S, Navarro-Muñoz JC, Terlouw BR, van der Hooft JJJ, van Santen JA, Tracanna V, Suarez Duran HG, Pascal Andreu V, Selem-Mojica N, Alanjary M, Robinson SL, Lund G, Epstein SC, Sisto AC, Charkoudian LK, Collemare J, Linington RG, Weber T, Medema MH. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
MIBiG 2.0: a repository for biosynthetic gene clusters of known function By Satria A Kautsar, Kai Blin, Simon Shaw, Jorge C Navarro-Muñoz, Barbara R Terlouw, Justin J J van der Hooft, Jeffrey A van Santen, Vittorio Tracanna, Hernando G Suarez Duran, Victòria Pascal Andreu, Nelly Selem-Mojica, Mohammad Alanjary Published in: Nucleic Acids Research DOI: 10.1093/nar/gkz882 ABSTRACT Abstract Fueled by the explosion of (meta)genomic data, genome mining of specialized metabolites has become a major technology for drug discovery and studying microbiome ecology. In these efforts, computational tools like antiSMASH have played a central role through the analysis of Biosynthetic Gene Clusters (BGCs). Thousands of candidate BGCs from microbial genomes have been identified and stored in public databases. Interpreting the function and novelty of these predicted BGCs requires comparison with a well-documented set of BGCs of known function. The MIBiG (Minimum Information about a Biosynthetic Gene Cluster) Data Standard and Repository was established in 2015 to enable curation and storage of known BGCs. Here, we present MIBiG 2.0, which encompasses major updates to the schema, the data, and the online repository itself. Over the past five years, 851 new BGCs have been added. Additionally, we performed extensive manual data curation of all entries to improve the annotation quality of our repository. We also redesigned the data schema to ensure the compliance of future annotations. Finally, we improved the user experience by adding new features such as query searches and a statistics page, and enabled direct link-outs to chemical structure databases. The repository is accessible online at https://mibig.secondarymetabolites.org/. INTRODUCTION Plants, microbes and fungi produce a large variety of specialized metabolites that are often uniquely found in one or a few species. From the dawn of civilization, humans have tapped into this treasure trove for medicinal, economic or recreational purposes. Within the last decade, genome-based discovery of specialized metabolites has become a widely adopted practice within both the scientific community and commercial settings. The magnitude of these efforts is continuously growing because of the ongoing increase in availability of genome and metagenome assemblies in public databases. These sequences can be mined for the presence of Biosynthetic Gene Clusters (BGCs): multi-enzyme loci that encode the biosynthetic pathways for one or more specific compounds. Thousands of candidate BGCs have thus been identified using computational tools such as antiSMASH (1) and ClusterFinder (2). Databases like IMG-ABC (3) and antiSMASH-DB (4) store many thousands of such computationally predicted BGCs, potentially coding for a very diverse range of natural product classes. To unravel the function and novelty of current and future candidate BGCs, knowledge on previously characterized BGCs is essential. This calls for a standardized deposition and extraction of BGCs associated with molecules of known chemical structure, as this relevant knowledge is usually buried inside the text of scientific articles. A first step to this end was taken in 2013, when ClusterMine360 (5) appeared, the first database of BGCs with known products, containing data on around 300 gene clusters. In 2015, the MIBiG (Minimum Information about a Biosynthetic Gene Cluster) Data Standard and Repository was established, containing 1170 BGC entries that were manually curated through a community effort, the results of which could be accessed via a fairly simple web application (6). Now, the MIBiG repository has become a central reference database for BGCs of known function, and provides the basis for comparative analyses in antiSMASH (1) via the KnownClusterBlast module. It has enabled many computational analyses of BGC function and novelty central to both small and large-scale studies of microbes and microbial communities. For example, Crits-Cristoph et al. (7) recently used MIBiG to assess and highlight the exceptional novelty of BGCs across 376 metagenome-assembled genomes of uncultivated soil bacteria from understudied phyla, by showing that most of these BGCs lacked any homology to gene clusters from MIBiG. Similarly, Bahram et al. (8) used homology searches against MIBiG to identify fungal BGCs associated with antibacterial activity across 7560 metagenomic samples, based on a set of MIBiG gene clusters whose products could be annotated with this activity; thus, they were able to show that the abundance of such ‘antibacterial’ BGCs correlated with the presence of antimicrobial resistance genes across soils. Yet another usage is illustrated by the ClusterCAD tool (9), which sources BGC data from MIBiG as a starting point for the computer-aided design of new biochemical pathways. Here, we provide an updated MIBiG version 2.0, which has been significantly expanded through the addition of 851 new entries over the past five years (Figure 1). Moreover, we performed extensive re-annotation of the entire database, increasing the overall data quality by improving the data schema, by adding hundreds of literature references and chemical structures and by providing cross-links to recently emerged databases of chemical structures and analytical data. Finally, we added useful functionalities to the online repository to make it more user-friendly, by enabling fast filtering based on compound names, taxonomic identifiers or biosynthetic classes, and facilitating the building of Boolean queries. [Figure: Distribution of taxonomic kingdoms and biosynthetic classes for all BGCs present in and added to MIBiG 2.0. Statistics are taken after the restructuring effort, and include retired entries. New entries are depicted in light green. Only (hybrid) classes comprising more than one BGC entry are listed in the figure. The intersection diagram is generated using the UpSetR tool (14).] METHODS AND IMPLEMENTATION Manual curation of entries Since its inception in 2015, MIBiG has provided an online submission form for adding new entries. To submit a new entry, a user starts by requesting a MIBiG accession number. This is done through submitting the product name(s) and the sequence information of the BGC, preferably in the form of a set of coordinates corresponding to the BGC’s position within an NCBI Genbank accession. After the request is approved by MIBiG staff, the workflow subsequently provides an extended entry form where users can input more detailed information. This crowdsourcing, open-for-all approach has garnered 140 new entries since 2015, with contributions coming from various experts all over the world. Because not all newly characterized BGCs are submitted to the database, we actively complemented this crowdsourcing approach by periodically organizing in-house ‘Annotathons’, where multiple scientists sat together for an entire day to work on MIBiG curation (Supplementary Table S1). This has yielded 702 new entries, and annotation quality improvements for over 600 BGCs. More recently, we have introduced an additional MIBiG curation process into the classroom environment with the help of a comprehensive and very specific set of guidelines for the students (10,11). By giving one task to multiple students to work on independently, and later on having an expert (the teacher) to combine and validate the results, we have generated an additional 10 high quality BGC entries, for actinomycin, carbapanem, daptomycin, ebelactone, lipstatin, nocardicin A, obaflourin, oxazolomycin, salinosporamide and tabtoxin. Scaling up this process in the future may allow the annotations of many more important entries, which have remained incomplete, because, e.g. the scientists who have worked on the pathway are no longer active in the field. Data quality improvements The MIBiG specification needs to capture the architectural and enzymatic variety present in currently described BGCs, and needs to stay flexible enough to also accommodate future discovery of even more diverse clusters and